µÚËľüÒ½´óѧһ¾Å¾Å¶þÄê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧÊÔÌâ ѧ¿Æ×¨Òµ£º =BsV`p7rU
fn#8=TIDf
´«È¾²¡Ñ§ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ )^h6'h`
+>w]T\[1~
Ò». Ãû´Ê½âÊÍ(ÿÌâ4·Ö,¹²32·Ö) 0ju1>.p
uGKjZi
1. ICAM-1 k_=SDm a
Ae)xFnuq3
2. interleukin 12(IL-12) #u<Qc T@
gU9{~-9}
3. tumor infiltrating lymphocyte UN I< r
Er~ 17$b
4. TCR/CD3 complex ,N/@=As9$
f49kf**
5. hematopoietin receptor family ^s,3*cAU
LyUn!zV$(
6. individual idiotype(IdI) !\]^c
aCQtE,.
7. integrin ^Fk;t
tobE3Od4
8. colony-stimulatory factor (CSF) 6|97;@94
dzcF15H1
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© CB7dr&>
|%_C$s%
1. ÃâÒßÇòµ°°×ÖØÁ´µÄ»ùÒòÈçºÎ½øÐÐÀà±ðת»»(class switching )? (1/Sf&2i
:\](m64z;
2. ¼òÊöɱÉËÐÔTϸ°û(Tc)ɱÉ˲¡¶¾¸ÐȾ°Ðϸ°ûµÄ»úÀí¡£ *miG<
S :HOlJze
3. ÉúÎïÓ¦´ðµ÷½Ú¼Á( biological response modifier,BRM)Ö÷ÒªÓÐÄļ¸Àà?¼òÒª½éÉÜÔÚ´«È¾ÐÔ¼²²¡·ÀÖÎÖеÄ×÷Óᣠ/iW+<@Mas
H7O~So*N5
4. ¼òÊö¿¹ÔÌá³Êϸ°û(APC)Ó븨ÖúÐÔTϸ°û(Th)Ï໥×÷ÓõĹØÏµ¡£ LPs%^*8(2
",r
v%i2 f
Èý. ÎÊ´ðÌâ(ÿÌâ18·Ö,¹²36·Ö) tZxx#v`
s"L&y <?)
1. ÊÔÊö¸ÉÈÅËØµÄ·ÖÀ༰ÆäÉúÎïѧ×÷ÓÃÌØµã¡£Ö÷Òª¿ÉÒÔÖÎÁÆÄÄЩ´«È¾ÐÔ¼²²¡?¼òÊö¸ÉÈÅËØ¼ì²âµÄ·½·¨ºÍÔÀí¡£ HC0juT OiO
$C16}^
2. ºÎΪ»ùÒò¹¤³Ì¿¹Ìå?Ŀǰ¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? µÚËľüÒ½´óѧһ¾Å¾ÅÈýÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 1. CD4 2. T cell receptor(TCR) KbJ6U75|f
D#jwI,n}x
3. immunoglobulin superfamily (IgSF) ET*A0rt
+in)(a.
4. selectin NP>v@jO
:@w~*eK ~
5. anti-idiotypic antibody (¦ÁId) >}k*!J|
goM;Pf
"<
6. major histocompatibility complex(MHC) ~tUZQ5"
ODJ"3 J
7. immunotolerance q4BXrEOw
bLT3:q#s
8. biological reponse modifier(BRM) 3}L3n*Ft#.
zK0M WyXO
9. immune reponse gene (Ir gene)
K^{j$
[*%lm9 x
10. reshaped antibody (or reconstituted antibody) /N0mF< P
#rHMf%0
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© v}>g* @
g5BL"Dn
1. ¼òÊö°×ϸ°û½éËØ6(IL-6)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¡£ Gm+D1l i
l,n_G/\
2. ϸ°û¶¾ÐÔTÁܰÍϸ°û(Tc»òCTL)Ó뿹ÌåÒÀÀµµÄϸ°û½éµ¼µÄϸ°û¶¾(ADCC)ɱÉË»úÀíÓкβ»Í¬? p{?duq=
b~;:[ #
3. ¼òÊöµÚ¢ôÐÍ(³Ù·¢ÐÍ)±ä̬·´Ó¦µÄ·¢Éú»úÀí¡£ 1I;q@g0
RqROl!6
4. NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄ±íÃæ±ê¼Ç?NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄÉúÎïѧ»îÐÔ? %
:G78.
P IG,a~
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö) ¹©´«È¾²¡Ñ§×¨ÒµÊÔÌ⣺
^;II@n
i
|E13W
1. »úÌåÓÐÄÄЩÃâÒßϸ°ûºÍÃâÒß·Ö×Ó²ÎÓ뿹²¡¶¾¸ÐȾ?ËüÃÇÊÇÈçºÎ·¢»Ó²¡¶¾ÃâÒß×÷ÓõÄ? cg )(L;
HOD?i_
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚ²¡¶¾Ñ§ÖÐÓÐÄÄЩÖ÷ÒªÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ f}dlQkZ(
( w4XqVT
¹©Ïû»¯ÄÚ¿Æ×¨ÒµÊÔÌ⣺ \]
Y<d
:F d1k
Jm
1. ĿǰÌåÄÚºÍÌåÍâ¼ì²âÖ×Áö»¼ÕßÃâÒß¹¦Äܵķ½·¨Ö÷ÒªÓÐÄÄЩ?·Ö±ðÐðÊöÿÖÖ·½·¨µÄÔÀíºÍ½á¹û²â¶¨? UAjN
1uo |a
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚÖ×ÁöѧÖÐÓÐÄÄЩÖ÷ÒªµÄÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ JKKp5~_~
/A5=L<T6F
µÚËľüÒ½´óѧһ¾Å¾ÅËÄÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: UXZ3~/L5 O
52^3N>X4X
´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: +4J'> dr
W'Gh:73'}
̉񧄤 /XG7M=A$o
T7YJC,^m
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 5hqXMs
]V fp,"op
1. CD8 [YQtX_;w
+VIEDV+
2. T cell receptor ¦Á and ¦Â chain (TCR¦Á¦Â ) Jv(E'"H
uUl ;}W
3. immunoglobulin fold(Ig fold) HJr*\%D}1
d*!H&1L
4. cadherin (Ca-dependent cell adhesion moleculers) qPN
;8F6a:\v
5. idiotype-anti-idiotypic antibody immune network theory KW0KXO06a
v&sp;%I6=
6. HLA class II antigen YC{7;=Pf
uPFbKSJj
7. complementarity-determining region (CDR) 84(jg P
HDo=W qG
8. perforin(or pore-forming protein ,PFP) b9f5
RplcM%YJn
9. high affinity IL-2 receptor
L8;`*H
ieyqp~+|4$
10. artificial active immunization a(U/70j
ZDrTPnA[
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© or
`"{wop
BD ,3JDqT
1. ¼òÊö°×ϸ°û½éËØ2(IL-2)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¼°ÆäÔÚÁÙ´²ÖÎÁÆÖеÄÓ¦Óᣠ@XF/hhGE_y
)o_$AbPt
2. Çë±È½ÏµÚ¢ñÐÍ(ËÙ·¢ÐÍ)³¬Ãô·´Ó¦ÓëµÚ¢ôÐÍ(³Ù·¢ÐÍ)³¬Ãô·´Ó¦µÄ·¢²¡Ìص㡣 Zfr?(y+3
4p&SlJ
3. ÊÔÊö·ÖÃÚÐÍIgA(secretory IgA)µÄ½á¹¹ÌصãºÍºÏ³É·ÖÃÚ¹ý³Ì¡£ 3TD!3p8
$r)nvf`\
4. ÊԱȽÏT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(Èç±íÃæ¿¹Ô¡¢±íÃæÊÜÌåµÈ)µÄÒìͬµã¡£ XG6UV('
h9{'w
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö¡£Çë×¢Ò⣺ÿλ¿¼ÉúÖ»ÄÜ´Ó1¡¢2ÌâÖÐѡһÌâ,3¡¢4ÌâÖÐѡһÌâ,¹²´ðÁ½Ìâ,¶à´ðÕß²»¼Æ·Ö¡£) 1. Ŀǰ¼ì²âϸ°ûÒò×ÓÖ÷ÒªÓÐÉúÎïѧ»îÐÔ¼ì²â·¨ºÍÃâÒßѧ¼ì²â·¨,Çë¾ÙÀý·Ö±ðÐðÊöÁ½ÖÖ·½·¨µÄʵÑéÔÀí¡£ 20uR? /|@
j@s,5:;[
2. ΪÁ˱ÜÃâIgG¿¹ÌåFc¶Î·ÇÌØÒìÐÔ×÷ÓÃ,³£Ó¦ÓÃθµ°°×øˮ½âµÄF(ab¡¯)2¶Î,ÊÔÎÊÈçºÎÓ¦ÓÃSDS-PAGE·½·¨¶ÔF(ab¡¯)2½øÐмø¶¨? Xp3cYS*u
`!T6#6h
3. ÊÔÊö¿¹Ö×Áö»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ q}R"
;,&1
4. ÊÔÊö¿¹²¡¶¾»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ ¡¡ ? Kn~fs8
whg?X&j\V
µÚËľüÒ½´óѧһ¾Å¾ÅÎåÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ I-q@@!=
WS0RvBvb
ѧ¿Æ×¨Òµ£ºÃâÒßѧ¡¢´«È¾²¡Ñ§¡¢Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ 'W j Q
5G=CvGu
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© J`3pXc$.
4d3PF`,H`
1. immunoglobulin gene rearrangement ,G,T&W
yHoj:f$$x
2. the common chain of cytokine receptor (or a cytokine receptor subunit shared by some cytokine receptors) Z)(C7,Xu
2S8/
lsB
3. flow cytometry(FCM) %P9Zx!i>
S?=2GY
4. carrier effect ^f1}:g
?z60b=f8
5. positive selection of T lymphocytes in thymus Fk
1M5Dm
F:M3^I
6. mouse TH1(Th1) and TH2(Th2) subsets ]0dp^%
{{=7 mbc
7. perforin (pore-forming protein ,PFP) n|L.dBAs]
")(1z@
8. ADCC(antibody-dependent cell-mediated cytotoxicity) } `
ScfW;
9. SH-2(src-homology region 2) ^ tm,gh
-acW[$t
10. Ab2¦Â (internal image) Cl>'K*$F
sbNCviKP
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© 1p9f& w
.f&,~$e4
1. ½üÄêÀ´ÔÚÈËÀà°×ϸ°û·Ö»¯¿¹Ô(CD)Ñо¿ÁìÓòÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? C`knFGb
fX} dh
9
2. ²ÎÓë»î»¯Tϸ°ûÓë»î»¯Bϸ°ûÏ໥×÷ÓõķÖ×ÓÖ÷ÒªÓÐÄÄЩ?¼òÊöÆä½á¹¹ºÍ¹¦ÄÜ? [>?B`1;@
^X0<ZI
3. ÊÔÊöHLAÔÚÁÙ´²ÉϵÄÖ÷ÒªÓ¦Óᣠ0V srAV0
+69sG9BA
4. Àý¾ÙÈýÖÖ´ÓÈËÍâÖÜѪµ¥¸öºËϸ°û(PBMC)Öд¿»¯Tϸ°ûµÄ·½·¨,·Ö±ðÐðÊöÆäʵÑéÔÀíºÍÖ÷Òª²Ù×÷²½Öè¡£ |$9k
z31
]rHdG^0uss
5. ÆÀ¼Ûºìϸ°ûÉú³ÉËØ(EPO)¡¢¸ÉÈÅËØ(IFN)ºÍ¼¯Âä´Ì¼¤Òò×Ó(CSF)ÔÚÁÙ´²Ä³Ð©¼²²¡µÄÓ¦ÓᣠpU`Q[HOs
UTm
X"Li
Èý. Ñ¡ÔñÎÊ´ðÌâ(ÿÌâ10·Ö,¹²20·Ö¡£Çë°´±¨¿¼×¨Òµ´ðÌâ,Èç´ð·Ç±¾×¨ÒµÌâ»ò¶à´ðÌâ¾ùÊÓΪÎÞЧ¡£) <t
gJ-rnL
b^5rV5d
ÃâÒßѧרҵ£º 7PP76$
kV6T#RVob
1. ÊÔÊöϸ°ûÒò×ÓÊÜÌåÖÐ,Ig³¬¼Ò×å¡¢ÔìѪÒò×ÓÊÜÌ峬¼Ò×å¡¢Éñ¾Éú³¤Òò×ÓÊÜÌ峬¼Ò×åÒÔ¼°Ç÷»¯Òò×ÓÊÜÌ峬¼Ò×åµÄÖ÷Òª½á¹¹Ìصã,ÿ¸ö³¬¼Ò×åÀý¾Ù³ö2¸ö³ÉÔ±¡£ aeE9dV~
i>q]U:U
2. ÊԱȽÏÈËT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(±íÃæ±ê¼Ç)µÄÒìͬµã,ËüÃÇ·Ö±ð²ÎÓëÄÄЩÖ÷ÒªµÄÃâÒß¹¦ÄÜ? + lU:I
],&WA?>G
´«È¾²¡Ñ§×¨Òµ£º HRje4=:
SS@#$t:
1. ÈËÀàÃâÒßȱÏݲ¡¶¾(HIV)¸ÐȾÈËÌåºó,ÃâÒß¹¦Äܿɷ¢ÉúÄÄЩÖ÷ÒªµÄ±ä»¯?»úÀíÊÇʲô?ÈçºÎ½øÐÐÏàÓ¦µÄÃâÒßѧ¹¦Äܼì²â£¿ 4 K{4=uU
&FIPEe#n
2. ÇëÆÀÊöÉö×ÛºÏÕ÷³öѪÈȲ¡¶¾(HFRSV)¸ÐȾºó»úÌåÃâÒßѧ±ä»¯µÄÓ벡ÀíËðÉ˵ĹØÏµ¡£ -&D~TL#
&D>e>]E|P
Ïû»¯×¨Òµ£º &T}~h^/t
W<u63P
1.ÊÔÊöÓëÏû»¯ÏµÍ³ÓйصÄÖ×ÁöÏà¹Ø¿¹ÔÑо¿µÄ½øÕ¹¡£ KE&Y~y8O\
C B
=H1+
2.¼òÊöճĤÏà¹ØÁܰÍÑù×éÖ¯(mucosal assiociated lymphoid tissue,MALT)µÄ×é³ÉºÍ¹¦ÄÜÌØµã¡£·ÖÃÚÐÍIgAÊÇÈçºÎ½øÐкϳɺͷÖÃÚµÄ? AAxY{Z-4
* pyi;
µÚËľüÒ½´óѧһ¾Å¾ÅÁùÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ÃâÒßѧÊÔÌâ }*hY#jo1
Y)g7
E"
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© j#9p0[
;Q:^|Fw!F
1. Fas(CD95)/FasL Txj%o5G
U\&kT/6vh
2. common chain of cytokine receptor :@I?JSi
|Vs|
&0
3 . TCR/CD3 complex L,!Z
|{k;pfPV
4. negaive selection of thymocytes LDN'o1$qo
h6}oRz9=g
5. artificial active immune I1=YSi;A
s03DL
6. anti-idiotypic J
vw~b\
W@GcE;#-
7. IgSF aSi:(w
^QTl (L
8. Integrin 0I* ^VGZ
O?L_9L*
9. chemokine M6vW}APH[n
<~!7? ak
10. B7/CD28 ;XSRG*3j~4
"tBdz V
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£© 3M
8P%
}P#%aE&-
1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£ VG*BAFs
d*khda;Vj
2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£ N*$<Kjw
Bs =V-0
3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ 73P=<3
"zc@(OA[z
4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£ 6_
=qpP-?
,*Y*ov23aQ
5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£ @/l{
MB"uJUk
µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ yGT"k,a
C6,GgDH`
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© #HWz
.Wb
d#Sc4xuf
1. B7/CD28 [6K2V:6:
h?j;*|o-
2. Th1 subset Vo+d3
o+;=C@,'
3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£© [q cT?h
z@>z.d4
4. antibody affinity maturation gGw6c" FRQ
KSIH1E
5. AP-1 |xZDc6HDW
~'dnrhdme
6. single chain variable fragment£¨ScFv£© Ky|Hi3?
\hdR&f5q
7. NK cell receptor 0t}=F4@&a
5
usfyY]z
8. Zinkernagel-Doherty phenomenon }U7>_b2
583ej2HPg
9. Ig fold [?RLvhU|
jPPaL]
10. CD40/CD40L Vm'ReH
}1TfKS]m>
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£© nf,>l0,,'
Il2DZ5-
)
1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£ Id]WKL:
fdho`juFa
2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿ 5U|f"3&8
[aO"9
3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿ ?8-e@/E#x
1(w0*`
Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩ x?:WR*5w
EM vV
1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£ k:7UU4M
5
\VHi
2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£ ;ZjQy,H%
g.DgJX&i
3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£ GPP~*+n
~l CG37
Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ £¨ÃâÒßѧרҵºÍרҵ»ù´¡£©
=!U{vT
t@}<&{zk
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© \5s!lv*&
>P\Tnb"Q\
1.Co-stimulators (or co-stimulating molecules) VxjH
B?)
{nryAXK
2.NK-kB Mk@ _uPm
'G-VhvMv
3.Immunoglobulin superfamily <+_OgF1G
w$Dp m.0(
4.antigen-presenting cell (APC) nn#A-x}~;b
_<t3~{qUT
5.death domain %3xH<$Gq5
yaR|d3ef?4
6.CCR and CXCR aEZl ICpU7
7t@j
j%F
7.Lectin (or mitogen) t$\]6RU
?)]sfJG
8.Clusters of differentiation, CD)
vf5[x!4
!o*oT}6n
9.B7 family
diTzolY7
K<s\:$VVh
10.Cytotoxic T lymphocyte, CTL) _BR>- :Jr
{_k 6 t
11.IL-15 and IL-15 receptor (IL-15R) w'
L;`k;Q
dZnq 96<:|
12.MHC restriction nH[@
EL
\9ap$
13.Affinity-chromatography [fO]oTh
Lo;T\CN
14.Cyctosprin A, CsA P6IhpB59
f3yZx!K_Br
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) zEks4yd
*Ru
Uf
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© Nk^#Sa?
Dm4\Rld{
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 \J1Jn~
u9VJ{F
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ %PkJ7-/b|^
6J&L5E
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ 0eUsvzz15
IClnh1=
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© \&W~nYXq"
F;MFw2G
ÃâÒßѧרҵ£º u1>| 2D
a2p<HW;)m
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ BQw#PXp3
501|Y6ptl
Ïû»¯ÄÚ¿Æ£º 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ j_ :4_zdBy
b`%/*
ѪҺ²¡Ñ§×¨Òµ£º 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿ G]5'U"c j3
PW.W.<CL
Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ (רҵ»ù´¡: ÃâÒßѧ) <\yM{
V\
oYqlN6n,=6
Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö) c: #1Aym
`Jz"rh-M
1. ADCC(antibody dependent cell-mediated cytotoxicity) 4$vya+mAk5
.eJ4F
-V
2. »·æß¾úËØ(cyclosporin) L6U[H#3(
#msk'MVt
3. KIR(killer cell inhibitory receptor) G?8,&jP~T
J}<k`af
4. HLDA(human leucocyte differentiation antigen) ]36 R_Dp
O2A Z|[*I
5. Interleukin 18(IL-18) ggX'`bK
Q{mls
6. ÕûºÏËØ(integrin) m"@M~~bh
`EV[uj&1S
7. Fas/FasL l=bB,7gL
k,b(MAiQ0
8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå) Gl}=Q7
'{U56^b]
9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM) E%jOJA
USe"1(|E
10. Th1/Th2 F]SexP4:A
<@5#
11. »ùÒòÒßÃç(DNAÒßÃç) l0[jepmpiT
c?b?x
6 2
12. chemokines and chemokine receptor N$?mula
wdoA>a?q
13. ÃâÒßÄÍÊÜ nN/v7^^
6$@Pk<w
14. ¹²´Ì¼¤·Ö×Ó GEIMCg(TRj
E{Y0TZ+
15. ËÀÍö½á¹¹Óò(death domain) )v8;\1`s:
K'N\"Y?>
¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö) BeaX 0#\
[
,|KVc=&H
1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬? aztP`S$h
Joq9.%7Q
2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦ÓᣠZ(*nZT,
@MAk/mb
&
£¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î M+)%gnq`u
RAXqRP,iw
£¨2£©1977Ä꣺·ÅÉäÃâÒß·¨ \9@*Jgpd6*
i
LK8Wnrq
£¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå D\N-ye1LE
PFUb\AY
£¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹ 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£ L'"20=sf
7b:oz3 ?PI
Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ) ÎÊ´ðÌâ(ÿÌâ25·Ö) yTkYPx
a%*W^R9Ls
1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£ @*%Q,$
roj/GZAy"
2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿ ;=*b:y Y
#}:VZ2Z
3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£ 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£